Lenvatinib or Regorafenib in combination with Cdk5 inhibition – new promising therapeutic approaches for treating HCC patients

Petra Huber-Cantonati, T Mähr, MA Ardelt, J Pachmayr

Research output: Contribution to conference › Poster

Original language	English
Publication status	Published - 2022
Event	Science Get Together - Salzburg/Nürnberg - virtuell, Austria Duration: 1 Jul 2022 → …

Conference with scientific content	Science Get Together
Country/Territory	Austria
City	Salzburg/Nürnberg - virtuell
Period	1/07/22 → …

Cite this

@conference{48e8b6e92d6c438691d18f254f2bdb1b,

title = "Lenvatinib or Regorafenib in combination with Cdk5 inhibition – new promising therapeutic approaches for treating HCC patients",

author = "Petra Huber-Cantonati and T M{\"a}hr and MA Ardelt and J Pachmayr",

year = "2022",

language = "English",

note = "Science Get Together ; Conference date: 01-07-2022",

}